Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Zorrilla

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Brain, Behavior, and Immunity|December 10, 2013
Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed miceEric P Zorrilla, Bruno Conti
Psychopharmacology|March 8, 2017
Don't stress about CRF: assessing the translational failures of CRF<sub>1</sub>antagonistsSamantha R Spierling, Eric P Zorrilla
Expert Opinion on Investigational Drugs|June 24, 2004
The therapeutic potential of CRF1 antagonists for anxietyEric P Zorrilla, George F Koob
Neuroscience and Biobehavioral Reviews|December 11, 2012
Amygdalostriatal projections in the neurocircuitry for motivation: a neuroanatomical thread through the career of Ann KelleyEric P Zorrilla, George F Koob
Addiction Biology|June 30, 2012
Stress history increases alcohol intake in relapse: relation to phosphodiesterase 10AMarian L Logrip, Eric P Zorrilla
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2010
Neurobiological mechanisms of addiction: focus on corticotropin-releasing factorGeorge F Koob, Eric P Zorrilla
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 14, 2011
Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist viewGeorge F Koob, Eric P Zorrilla
Frontiers in Behavioral Neuroscience|September 11, 2019
Corrigendum: Impulsivity Derived From the Dark Side: Neurocircuits That Contribute to Negative UrgencyEric P Zorrilla, George F Koob
Frontiers in Integrative Neuroscience|May 1, 2014
Differential changes in amygdala and frontal cortex Pde10a expression during acute and protracted withdrawalMarian L Logrip, Eric P Zorrilla
Drug Discovery Today|March 9, 2010
Progress in corticotropin-releasing factor-1 antagonist developmentEric P Zorrilla, George F Koob
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Brain, Behavior, and Immunity|December 10, 2013
Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed miceEric P Zorrilla, Bruno Conti
Psychopharmacology|March 8, 2017
Don't stress about CRF: assessing the translational failures of CRF<sub>1</sub>antagonistsSamantha R Spierling, Eric P Zorrilla
Expert Opinion on Investigational Drugs|June 24, 2004
The therapeutic potential of CRF1 antagonists for anxietyEric P Zorrilla, George F Koob
Neuroscience and Biobehavioral Reviews|December 11, 2012
Amygdalostriatal projections in the neurocircuitry for motivation: a neuroanatomical thread through the career of Ann KelleyEric P Zorrilla, George F Koob
Addiction Biology|June 30, 2012
Stress history increases alcohol intake in relapse: relation to phosphodiesterase 10AMarian L Logrip, Eric P Zorrilla
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2010
Neurobiological mechanisms of addiction: focus on corticotropin-releasing factorGeorge F Koob, Eric P Zorrilla
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 14, 2011
Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist viewGeorge F Koob, Eric P Zorrilla
Frontiers in Behavioral Neuroscience|September 11, 2019
Corrigendum: Impulsivity Derived From the Dark Side: Neurocircuits That Contribute to Negative UrgencyEric P Zorrilla, George F Koob
Frontiers in Integrative Neuroscience|May 1, 2014
Differential changes in amygdala and frontal cortex Pde10a expression during acute and protracted withdrawalMarian L Logrip, Eric P Zorrilla
Drug Discovery Today|March 9, 2010
Progress in corticotropin-releasing factor-1 antagonist developmentEric P Zorrilla, George F Koob
Pageof 11